BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6201073)

  • 1. Proteoglycan-targeted antibodies as markers on non-Hodgkin lymphoma xenografts.
    Kopper L; Bankfalvi A; Mihalik R; Glant TT; Timar J
    Cancer Immunol Immunother; 1990; 32(2):137-42. PubMed ID: 2289206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights.
    Christian SL
    Onco Targets Ther; 2022; 15():1391-1402. PubMed ID: 36425299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of an abdominal mass: follicular lymphoma.
    Walker TL; Lopez GE
    Perm J; 2011; 15(4):61-4. PubMed ID: 22319418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic expression of T lymphocytes in thymus and peripheral lymphoid tissues.
    Hsu SM; Jaffe ES
    Am J Pathol; 1985 Oct; 121(1):69-78. PubMed ID: 3931482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocytoid B-cell lymphoma. A novel B-cell neoplasm.
    Sheibani K; Sohn CC; Burke JS; Winberg CD; Wu AM; Rappaport H
    Am J Pathol; 1986 Aug; 124(2):310-8. PubMed ID: 3488686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
    Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
    Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A histogenesis of malignant lymphoma, small cleaved cell of the B cell type and intermediate lymphocytic lymphoma (mantle zone lymphoma). An immuno- and enzymehistochemical study.
    Abe M; Ono N; Nozawa Y; Hojo H; Wakasa H
    Virchows Arch A Pathol Anat Histopathol; 1988; 413(3):205-13. PubMed ID: 3135658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary mediastinal clear cell lymphoma of B-cell type.
    Möller P; Lämmler B; Eberlein-Gonska M; Feichter GE; Hofmann WJ; Schmitteckert H; Otto HF
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(1):79-92. PubMed ID: 3085342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody phenotyping of B-cell non-Hodgkin's lymphomas. The Southeastern Cancer Study Group experience.
    Borowitz MJ; Bousvaros A; Brynes RK; Cousar JB; Crissman JD; Whitcomb CC; Kerns BJ; Byrne GE
    Am J Pathol; 1985 Dec; 121(3):514-21. PubMed ID: 2933960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIg-E- ("null-cell") non-Hodgkin's lymphomas. Multiparametric determination of their B- or T-cell lineage.
    Knowles DM; Dodson L; Burke JS; Wang JM; Bonetti F; Pelicci PG; Flug F; Dalla-Favera R; Wang CY
    Am J Pathol; 1985 Sep; 120(3):356-70. PubMed ID: 2931028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia.
    Adachi M; Cossman J; Longo D; Croce CM; Tsujimoto Y
    Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2771-4. PubMed ID: 2704746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
    Hsu SM; Hsu PL
    Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tonsillar mapping of determinants found on normal lymphoreticular (T,B,K, immature and macrophage) and myeloblastic leukemia cells.
    McMillan EM; Stoneking L; Humphrey GB; Rapacz J
    Am J Pathol; 1987 Mar; 126(3):452-63. PubMed ID: 2435159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD5-positive B-cell malignancies frequently express cross-reactive idiotypes associated with IgM autoantibodies.
    Kipps TJ; Robbins BA; Tefferi A; Meisenholder G; Banks PM; Carson DA
    Am J Pathol; 1990 Apr; 136(4):809-16. PubMed ID: 1691593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
    Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
    Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
    Harris NL; Bhan AK
    Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
    Abe M; Wakasa H
    Fukushima J Med Sci; 1994 Dec; 40(2):85-101. PubMed ID: 7642169
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.